Yes @Halime we both hold the same share
And all the more perplexing, I wonder how do you arrive at the second assertion in this;
I have said many times before that ARDS approval is the key and catalyst for future R&D.
Bearing in mind COVID-19/ARDS is the 4th Phase 3 trial in the Mesoblast queue, plus Ryoncil working through the BLA process. Or you could say the current running trial is the 5th Phase 3 trial in the Mesoblast queue, the only one still not completed, and we only know the outcome of 1 of those 5.
MSB Trading - 2020, page-17535
-
- There are more pages in this discussion • 5,626 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |